QT Indexes in Cirrhotic Patients: Relationship with Clinical Variables and Potential Diagnostic Predictive Value
Overview
Authors
Affiliations
Background And Aims: A wide spectrum of cardiovascular changes characterizes cirrhosis, ranging from subclinical alterations to hyperkinetic syndrome. We looked for ECG markers of ventricular repolarization in a population of patients with cirrhosis in comparison to patients without cirrhosis and we investigated the relationship between these and other clinical and laboratory variables.
Methods: In 149 patients with cirrhosis and 152 controls, we measured QT maximum interval (QTmax), QT corrected interval (QTc), QT minimum interval (QTmin), QT dispersion (QTdisp), QT peak and T peak-to-end (TpTe).
Results: In subjects with cirrhosis, in comparison with controls, we observed a higher mean QTmax, mean QTc, mean QTmin, mean QTdisp and mean TpTe. At Cox regression analysis, diastolic blood pressure and beta-blocker treatment were significantly associated with mean QTmax, hypertension with mean QTmin and mean QTc, diastolic blood pressure, beta-blockers and ACE-inhibitors/ARBs with QT disp, and beta-blockers with TpTe. Analysis of ROC curves showed a significant area under curve towards cirrhosis diagnosis, respectively, for a cut-off value of > 400 msec of QTmax, > 360 msec of QTmin, > 450 msec of QTc, > 105 msec of TpTe and > 55 msec of QTdisp.
Conclusions: Our study shows that QT indexes are altered in cirrhotic patients and have a potential diagnostic predictive value.
Association of Cirrhosis and Cardiomyopathy.
Sezgin B, Cindoglu C, Uyanikoglu A, Yenice N Euroasian J Hepatogastroenterol. 2020; 9(1):23-26.
PMID: 31988863 PMC: 6969323. DOI: 10.5005/jp-journals-10018-1291.
Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity.
Tsiompanidis E, Siakavellas S, Tentolouris A, Eleftheriadou I, Chorepsima S, Manolakis A World J Gastrointest Pathophysiol. 2018; 9(1):28-36.
PMID: 29487764 PMC: 5823700. DOI: 10.4291/wjgp.v9.i1.28.
Drug-Induced QT/QTc Interval Shortening: Lessons from Drug-Induced QT/QTc Prolongation.
Malik M Drug Saf. 2016; 39(7):647-59.
PMID: 26968542 DOI: 10.1007/s40264-016-0411-3.